Patents Assigned to Advantex Bioreagents Llp
  • Publication number: 20030224465
    Abstract: The invention is directed to diagnostic and monitoring methods (assays) for cancer and kits that may be used in such methods. More particularly, an aspect of the invention relates to the use of activated Stat5 for diagnosing and monitoring breast cancer and predicting the effectiveness of cancer treatment. The invention also relates to the use of screening assays for discovering compounds that effect levels of activated Stat5.
    Type: Application
    Filed: March 3, 2003
    Publication date: December 4, 2003
    Applicant: Advantex Bioreagents Llp
    Inventors: Marja T. Nevalainen, Hallgeir Rui